Clark S A, Theg S M
Division of Biological Sciences, University of California, Davis 95616, USA.
Mol Biol Cell. 1997 May;8(5):923-34. doi: 10.1091/mbc.8.5.923.
Many thylakoid lumenal proteins are nuclear encoded, cytosolically synthesized, and reach their functional location after posttranslational targeting across two chloroplast envelope membranes and the thylakoid membrane via proteinaceous transport systems. To study whether these transmembrane transport machineries can translocate folded structures, we overexpressed the 17-kDa subunit of the oxygen-evolving complex of photosystem II (prOE17) that had been modified to contain a unique C-terminal cysteine. This allowed us to chemically link a terminal 6.5-kDa bovine pancreatic trypsin inhibitor (BPTI) moiety to prOE17 to create the chimeric protein prOE17-BPTI. Redox reagents and an irreversible sulfhydryl-specific cross-linker, bis-maleimidohexane, were used to manipulate the structure of BPTI. Import of prOE17-BPTI into isolated chloroplasts and thylakoids demonstrates that the small tightly folded BPTI domain is carried across both the chloroplast envelopes and the delta pH-dependent transmembrane transporter of the thylakoid membrane when linked to the correctly targeted OE17 precursor. Transport proceeded even when the BPTI moiety was internally cross-linked into a protease-resistant form. These data indicate that unfolding is not a ubiquitous requirement for protein translocation and that at least some domains of targeted proteins can maintain a nonlinear structure during their translocation into and within chloroplasts.
许多类囊体腔蛋白是由核基因编码,在细胞质中合成,然后通过蛋白质转运系统进行翻译后靶向运输,穿过两层叶绿体包膜和类囊体膜,到达其功能位置。为了研究这些跨膜运输机制是否能够转运折叠结构,我们过量表达了经过修饰的光系统II放氧复合体的17 kDa亚基(prOE17),使其含有一个独特的C端半胱氨酸。这使我们能够将一个6.5 kDa的牛胰蛋白酶抑制剂(BPTI)末端化学连接到prOE17上,从而构建嵌合蛋白prOE17-BPTI。使用氧化还原试剂和一种不可逆的巯基特异性交联剂双马来酰亚胺己烷来操纵BPTI的结构。将prOE17-BPTI导入分离的叶绿体和类囊体的实验表明,当与正确靶向的OE17前体相连时,紧密折叠的小BPTI结构域能够穿过叶绿体包膜和类囊体膜的依赖ΔpH的跨膜转运体。即使BPTI部分在内部交联成蛋白酶抗性形式,运输仍能进行。这些数据表明,展开并非蛋白质转运普遍需要的条件,并且靶向蛋白的至少一些结构域在转运到叶绿体中和在叶绿体内时能够维持非线性结构。